STOPCAP M1
Menu
  • Home
  • What is STOPCAP M1?
    • Systematic reviews
      • The FAME approach
      • Docetaxel
      • Zoledronic acid
      • Abiraterone
      • Prostate RT
      • Network
    • Surrogate outcomes
      • ICECAP M0
    • Repository of patient data
  • Who is running STOPCAP M1?
    • Programme Management Group
    • International Advisory Group
    • Key Collaborators
    • Collaborative Group
  • Patient & Public Involvement
    • PPI and STOPCAP M1
    • Recent STOPCAP M1 results
    • Prostate Cancer Resources
  • News
  • Sitemap

ICECAP in non-metastatic disease



Read more
ICECAP MOVEMBER WEBSITE
ICECaP Working Group. JNCI 2015. 107: 12; djv261
Xie W et al. JCO 2017. 35: 27; 3097-3104
  1. Home
  2. What is STOPCAP M1?
  3. Surrogate outcomes
  4. ICECAP M0

STOPCAP M1

MRC Clinical Trials Unit at UCL
90 High Holborn
2nd Floor
London
WC1V 6LJ

Email. mrcctu.stopcapm1@ucl.ac.uk

Twitter. https://twitter.com/MRCCTU

Quick links

  • Publications
  • Protocol
Funded by PCUK

Prostate Cancer UK is a registered charity in England and Wales (1005541) and in Scotland (SC039332). Registered company 02653887.
  • © 2025
  • Sitemap
  • Cookies
  • RSS
  • Page last updated: 13-May-2021 16:31